IDH1 and central nervous system cancer: The G-CIMP profile is tightly associated with IDH1/2 mutations and better outcomes for patients with IDH-mutated gliomas (Noushmehr et al., 2010; Malta et al., 2018; Tesileanu et al., 2021).